TEAM
Investing with an
experienced team
The Cordis Global Medical Technology Fund’s key competitive advantage is afforded by the Cordis Medical Advisory Panel and the Medical Device Industry Specialists, who provide us with a technical edge in the complex and niche investment field of medical devices.
The Cordis Medical Advisory Panel and the Medical Device Industry Specialists are a working team comprised of a judicious selection of highly qualified physicians, translational researchers, clinical engineers, and medical device industry experts from around the world, most affiliated to universities and research institutes, who have operating theatre and device application experience and in particular are early adopters of advanced medical devices in their own practices and research facilities.
PORTFOLIO MANAGEMENT TEAM


Simon Ford
Managing Director & Portfolio Manager


Jacob Celermajer
Senior Equity Analyst


Michael Cartmill
Medical Device Specialist


James Cook
Chief Investment Officer
MEDICAL ADVISORY PANEL - INIMITABLE CLINICAL INSIGHTS
As investors we are passionate and optimistic about the future of Medical Technology, but Cordis is more than just a group of investment analysts. Our team also includes a panel of medical professionals, globally recognised as leaders in their field. This is what we refer to as the Cordis Medical Advisory Panel. The Medical Advisory Panel is a team of leading physicians, translational researchers, clinical engineers, and medical device industry experts. Our Medical Advisory Panel is tightly integrated into our investment process, with formal quarterly meetings and more frequent informal discussions, which provide invaluable and inimitable insights into therapy direction, technology feasibility and expected future treatment paradigms.
Our Medical Advisory Panel is a fundamental part of our team, not just a resource to be called for comment. This highly integrated structure places us in a position to be exceptional at what we do.
In their position as global leaders of clinical practice and academic research, our Medical Advisory Panel will also be able to utilise their network of medical colleagues to add further depth and breadth to our investment process.
The ultimate goal of the Medical Advisory Panel is to add a unique edge to our portfolio. If we execute correctly, we believe that this unique aspect of our investment process will be able to generate repeatable excess returns for our investors.


Professor Michael
Vallely
Founder and Chairman of the Medical Advisory Panel


Professor David
Celermajer
Cardiologist, Sydney


Professor Michael
Mack
Cardiovascular Surgery, Texas


Professor John
Fraser
Intensive Care, Device VC
Brisbane


Professor Toshimasa
Okabe
Cardiac Electrophysiologist, Ohio, USA
DEVICE INDUSTRY ADVISORY PANEL
Our Device Specialists are another part of our highly integrated investment process and are intimately involved in providing inputs and insights to the investment team. This group is made up of world class leaders in device development and growth, having been in leadership roles at many global medical behemoths, such as Johnson & Johnson, Medtronic, Cochlear, Fisher & Paykel and Baxter. Throughout tenured careers in the field, our team has gained expertise in the design, manufacture, protection and sale of medical devices, and thus know the processes that we evaluate intimately. It is this deep knowledge that sets the inputs of this panel apart, and adds significant alpha to our investment process.


Donal O’Dwyer
Executive Director and Chairman of Investment Committee


Tim Fortin
Investment Committee
Former MD of Medtronic in ANZ
LEGAL AND OPERATIONS


Megan Inwood
General Counsel and Company Secretary


Rudi Engelbrecht
Director of Operations

